Mebendazole，Benzimidazole antihelmintic

Mebendazole, Benzimidazole antihelmintic

Be the first to review this product! Submit a review

|

(0 Publication)

MW 295.29 Da, Purity >99%. Benzimidazole antihelmintic. Tubulin-disrupting drug. Antitumour activity in vitro and in vivo. Inhibits growth and induces apoptosis.

查看别名

ABCC 4, ABL, ABL proto oncogene 1 non receptor tyrosine kinase, ABL1_HUMAN, AHR_HUMAN, AI838772, AIS, ANDR_HUMAN, AR, AR8, ATP binding cassette sub family C (CFTR/MRP) member 4, ATP-binding cassette sub-family C member 4, AW493413, Abelson murine leukemia viral oncogene homolog 1, Abelson tyrosine protein kinase 1, Ah receptor, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor, testicular feminization, spinal and bulbar muscular atrophy, Kennedy disease), Antigen NY-CO-13, Aromatic hydrocarbon receptor, Aryl hydrocarbon receptor, Aryl hydrocarbon receptor precursor, Atherosclerosis, susceptibility to, included, BAR, BCC7, BXR, Bcr/c abl oncogene protein, Bile acid receptor, CD309, CD309 antigen, Canalicular multispecific organic anion transporter, Canalicular multispecific organic anion transporter ABC superfamily, Cellular tumor antigen p53, Class E basic helix-loop-helix protein 76, DHTR, DKFZp686N23123, DNA replication inhibitor, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), EC 2.7.10.1, ER, ER-alpha, ER-beta, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, EST170205, ESTR B, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen-related receptor alpha, Estrra, FLJ11090, FLJ92943, FLK-1, FLK1, mouse, homolog of, Farnesoid X-activated receptor, Farnesol receptor HRR-1, Fetal liver kinase 1, GEMI_HUMAN, GMNN, Geminin, Geminin DNA replication inhibitor, HD 7, HD 7B, HD 9, HDAC, HDAC 7B, HDAC 9B, HDAC 9FL, HDAC9_HUMAN, HDL cholesterol, augmented response of, to hormone replacement, included, HDRP, HGNC:348, HRR 1, HUMARA, HYSP1, Histone deacetylase 4/5 related protein, Histone deacetylase 7, Histone deacetylase 7B, Histone deacetylase 9, Histone deacetylase 9A, Histone deacetylase-related protein, JTK7, KD, KIAA0744, KRD1, Kdr, Kennedy disease (KD), Kinase insert domain receptor, Kinase insert domain receptor (a type III receptor tyrosine kinase), LFS1, Ly73, MEF2 interacting transcription repressor protein, MEF2-interacting transcription repressor MITR, MGC104252, MGC112732, MITR, MOAT-B, MRP/cMOAT-related ABC transporter, MRP4_HUMAN, Multi-specific organic anion transporter B, Multidrug resistance-associated protein 4, Mutant tumor protein 53, Myocardial infarction, susceptibility to, included, NF-E2-related factor 2, NF2L2_HUMAN, NR1I2_HUMAN, NR3A1, NR3A2, NR3B1, NR3C4, NRF2, Nfe2l2, Nuclear factor, Nuclear factor (erythroid derived 2) like 2, Nuclear factor erythroid 2-related factor 2, Nuclear factor erythroid derived 2 like 2, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), ONR 1, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000018560, OTTHUMP00000039393, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, P150, P53_HUMAN, PAR, PAR q, PRR, Phosphoprotein p53, Pregnane X receptor, Protein-tyrosine kinase receptor flk-1, Proto oncogene tyrosine protein kinase ABL1, Proto-oncogene c-Abl, RIP 14, RNESTROR, RP24-311F12.2, RP3 369A17.3, RXR-interacting protein 14, Retinoid X receptor-interacting protein 14, SBMA, SCAN1, SMAX1, SXR, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid and xenobiotic receptor, Steroid hormone receptor ERR1, TFM, TRP53, TYDP, TYDP1_HUMAN, Testicular Feminization (TFM), Tp53, Transformation related protein 53, Tumor protein 53, Tumor protein p53, Tumor suppressor p53, Tyr-DNA phosphodiesterase 1, Tyrosine kinase growth factor receptor, Tyrosine-protein kinase ABL1, Tyrosyl-DNA phosphodiesterase 1, VEGFR, VEGFR-2, VGFR2_HUMAN, Vascular endothelial growth factor receptor 2, androgen receptor splice variant 4b, bA464I2.1, bA464I2.1 (ATP binding cassette, sub-family C (CFTR/MRP) member 4), bHLHe76, bcr/abl, c ABL, c abl oncogene 1 non receptor tyrosine kinase, c abl oncogene 1 receptor tyrosine kinase, erythroid derived 2, estrogen receptor related receptor alpha, hERR1, like 2, nuclear factor erythroid 2 like 2, p53 tumor suppressor, pregnane X nuclear receptor variant 2, soluble VEGFR2, tumor antigen p55, v abl, v abl Abelson murine leukemia viral oncogene homolog 1